These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25287518)
1. Implementation of a risk assessment program in a breast-imaging community practice. Destounis S; Arieno A; Morgan R Breast Cancer; 2016 Mar; 23(2):273-8. PubMed ID: 25287518 [TBL] [Abstract][Full Text] [Related]
2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
3. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients. Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291 [TBL] [Abstract][Full Text] [Related]
4. Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections. Fountzilas E; Konstantopoulou I; Vagena A; Apostolou P; Papadimitriou C; Christodoulou C; Tryfonopoulos D; Manousou K; Delimitsou A; Papamentzelopoulou M; Fountzilas G; Yannoukakos D; Fostira F Clin Breast Cancer; 2020 Apr; 20(2):152-159. PubMed ID: 31980407 [TBL] [Abstract][Full Text] [Related]
5. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer. Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859 [TBL] [Abstract][Full Text] [Related]
6. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499 [TBL] [Abstract][Full Text] [Related]
7. Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer. Noori SF; Gangi A; Nelson ME; Choi M; Mirzadehgan P; Bonk AK; Mirocha J; Amersi F; Giuliano AE Ann Surg Oncol; 2014 Oct; 21(10):3324-9. PubMed ID: 25047471 [TBL] [Abstract][Full Text] [Related]
8. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer. Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved? Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588 [TBL] [Abstract][Full Text] [Related]
11. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180 [TBL] [Abstract][Full Text] [Related]
12. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer. Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241 [TBL] [Abstract][Full Text] [Related]
13. Identification of germline BRCA1 mutations among breast cancer families in Northeastern Iran. Kooshyar MM; Nassiri M; Mahdavi M; Doosti M; Parizadeh A Asian Pac J Cancer Prev; 2013; 14(7):4339-45. PubMed ID: 23992000 [TBL] [Abstract][Full Text] [Related]
14. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727 [TBL] [Abstract][Full Text] [Related]
15. A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. Nomizu T; Matsuzaki M; Katagata N; Kobayashi Y; Sakuma T; Monma T; Saito M; Watanabe F; Midorikawa S; Yamaguchi Y Breast Cancer; 2015 Sep; 22(5):557-61. PubMed ID: 23242612 [TBL] [Abstract][Full Text] [Related]
16. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642 [TBL] [Abstract][Full Text] [Related]
17. Histological features of extratumoral breast lesions as a predictive factor of familial breast cancer. Mangia A; Tommasi S; Bruno M; Malfettone A; D'Amico C; Zito FA; Paradiso A; Simone G Oncol Rep; 2010 Jun; 23(6):1641-5. PubMed ID: 20428820 [TBL] [Abstract][Full Text] [Related]
18. Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics. Moreno L; Linossi C; Esteban I; Gadea N; Carrasco E; Bonache S; Gutiérrez-Enríquez S; Cruz C; Díez O; Balmaña J Clin Transl Oncol; 2016 Oct; 18(10):981-7. PubMed ID: 26742938 [TBL] [Abstract][Full Text] [Related]
19. Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. Chakraborty A; Mukhopadhyay A; Bhattacharyya D; Bose CK; Choudhuri K; Mukhopadhyay S; Basak J Fam Cancer; 2013 Sep; 12(3):489-95. PubMed ID: 23232912 [TBL] [Abstract][Full Text] [Related]
20. Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers. van den Broek AJ; van 't Veer LJ; Hooning MJ; Cornelissen S; Broeks A; Rutgers EJ; Smit VT; Cornelisse CJ; van Beek M; Janssen-Heijnen ML; Seynaeve C; Westenend PJ; Jobsen JJ; Siesling S; Tollenaar RA; van Leeuwen FE; Schmidt MK J Clin Oncol; 2016 Feb; 34(5):409-18. PubMed ID: 26700119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]